Hepatitis B Infection Prevalence, Genotype Distribution, and Knowledge of Mother- To-Child Transmission Among Antenatal Care Attendees in Yako, Rural Burkina Faso - Serge Ouoba

Conference on Liver Disease in Africa (COLDA) 2022

Hepatitis B Birth Dose Coverage Remains Dramatically Low in the Gambia and Has Been Disrupted by the COVID-19 Pandemic - Gibril Ndow

Conference on Liver Disease in Africa (COLDA) 2022

5-Year Results of a Treatment Program for Chronic Hepatitis B in Ethiopia - Hailemichael Desalegn Mekonnen

Conference on Liver Disease in Africa (COLDA) 2022

Integrating hepatitis B into HIV programs in sub-Saharan Africa: pilot clinic experience in Zambia - Wamundila Kawana

Conference on Liver Disease in Africa (COLDA) 2022

Can Integration Reduce Stigma? / Lessons Learned from HIV - Danjuma Adda, MPH, FIMS, Dip-IMS

Conference on Liver Disease in Africa (COLDA) 2022

Integrated Decentralized Guidelines for Care – WHO Guidelines - Philippa Easterbrook, MD, FRCP, MPH, DTM&H

Conference on Liver Disease in Africa (COLDA) 2022

Modelling Elimination Strategies in Africa - Shevanthi Nayagam, MBBS, MRCP, PhD

Conference on Liver Disease in Africa (COLDA) 2022

Vertical Transmission, Maternal Care, and Family Care - Manal El-Sayed, MD, PhD

Conference on Liver Disease in Africa (COLDA) 2022

Blood Safety & Surveillance - Yuyun S. Maryuningsih, MD, PhD

Conference on Liver Disease in Africa (COLDA) 2022

From Pandemic Response to Pandemic Recovery - Opportunities for Viral Hepatitis Elimination - John Ward, MD

Conference on Liver Disease in Africa (COLDA) 2022

Call for Action - “Call for Action - “We Need Testing and Treatment - NOW” - Bisi Bright, B.Pharm(Hons), MPH, FPCPharm, FPSN, C.Psych

Conference on Liver Disease in Africa (COLDA) 2022

Call for Action - “We Need Solutions” - Agnes Binagwaho, MD, M(Ped), PhD

Conference on Liver Disease in Africa (COLDA) 2022

Call for Action - “We Need (HQ) Data - To Plan Services” - Olufunmilayo Lesi, MD, MBA, FMCP

Conference on Liver Disease in Africa (COLDA) 2022

Call for Action - “We Need to Address the Challenges - Now” - The South African Experience - Wendy Spearman, MBChB, FCP, FRCP, MMed, PhD

Conference on Liver Disease in Africa (COLDA) 2022

Facilitating Education on Stigma and Discrimination – Train the Trainer Program (Taiwan Edition)

Community Perspective - Michael Meulbroek

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022

DDIs Relevant for COVID-19 Therapeutic Agents & Implementation Challenges - Fiona Marra, MPharm, MSc

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022

Session 1 - Abstract Discussion

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022

Policy Perspective - Heather-Marie Schmidt

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022

#4 A Phase 1 Drug-Drug Interaction Study to Investigate (...) - Myreen Tomas

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022

Current Situation of HIV and Monkeypox in Catalonia - Pep Coll, MD

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022

Emerging Strategies for Treating and Preventing Monkeypox, Ruth Byrne, MD

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022

Current COVID-19 Therapies and Variants - Stefano Bonora, MD

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022

#1Predicting Pharmacokinetics of Nirmatrelvir/Ritonavir in(...) - Erica Leertouwer

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022